ofloxacin and guaifenesin

ofloxacin has been researched along with guaifenesin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Benard, Y; Malbruny, B; Monrocq, N; Morel, C; Vergnaud, M1
Hayasaki, Y; Ito, K; Izumi, K; Kawazoe, K; Mikamo, H; Sato, Y; Tamaya, T; Yamada, Y1

Reviews

1 review(s) available for ofloxacin and guaifenesin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for ofloxacin and guaifenesin

ArticleYear
[Effects of levofloxacin once-a-day therapy on uterine cervicitis].
    The Japanese journal of antibiotics, 1999, Volume: 52, Issue:7

    Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Chlamydia Infections; Drug Administration Schedule; Female; Humans; Interleukin-6; Interleukin-8; Levofloxacin; Middle Aged; Mucus; Ofloxacin; Uterine Cervicitis

1999

Other Studies

3 other study(ies) available for ofloxacin and guaifenesin

ArticleYear
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
[Diffusion of an orally administered single dose of ofloxacin into human bronchial mucus].
    Pathologie-biologie, 1986, Volume: 34, Issue:5

    Topics: Administration, Oral; Anti-Infective Agents; Bronchi; Diffusion; Humans; Mucus; Ofloxacin; Oxazines; Time Factors

1986